Drug Discovery Biology

Uncovering the secrets of the human body

About us

Find out more about the Drug Discovery Biology theme.

Research labs

Our research groups are supported by government grant schemes and key industry partnerships, and collaborate extensively with national and international researchers.

Therapeutic areas

Learn about the five therapeutic areas that underpin the focus of our research.

PhD program

Discover what a higher degree with us entails and find out about available projects.

Research capabilities

Learn more about the techniques we employ.

Find a researcher

Build a collaboration



Contact us

For any enquiries please contact +61 3 9903 9614 or pharm-ddbenquiries@monash.edu.

Other research themes

See the latest news

The “master regulator” of inflammation: Monash researchers publish review on promising emerging drug target to treat chronic inflammatory states

Monash researchers, in collaboration with Queen Mary University of London, have published a state-of-the-art review on an emerging druggable target called FPR2, a key receptor involved in the regulation of inflammation.
4 August, 2022 Medicine & health

New development for hormone-free male contraceptive pill

A new study led by a team of Monash researchers working to develop a male contraceptive pill has identified that stinging nettle leaf extract has the potential to block a protein that controls the movement of sperm.
2 August, 2022 Medicine & health

New Monash biotech company receives funding to tackle cognitive disorders

A new Monash biotech company called Phrenix Therapeutics has received funding to advance research to develop new therapeutics for cognitive disorders, particularly in schizophrenia.
20 July, 2022 Medicine & health

Monash University scientists review breadth of preclinical models of diabetic heart failure in pursuit of new treatments

A team of leading drug researchers have published a high impact review that sets out to provide guidance on how pre-clinical studies of diabetic heart failure should be designed to most closely mimic the human disease.
4 July, 2022 Medicine & health

Dr Xin Zhang awarded 2021 Mollie Holman Award for FPPS best doctoral thesis

Her PhD thesis is entitled "Understanding structure and activation of GLP-1R".
1 July, 2022 Research
Amylin-template peptides activate amylin receptors through distinct mechanism to calcitonin-template peptides. The image was created by Dr Sarah Piper.

Monash University researchers make a breakthrough discovery for development of new obesity treatments

World first: Researchers from Monash University have harnessed cutting-edge technology to fill key gaps in our understanding of how promising new therapeutics could work for the treatment of obesity.
25 March, 2022 Medicine & health

MIPS, partners, launch new centre of excellence for cryo-electron microscopy

Monash University, together with principal partners The University of Melbourne, University of Wollongong, WEHI, today launched the Australian Research Council’s Industrial Transformation Training Centre for Cryo-electron Microscopy of
4 February, 2022 Industry & partnerships
Septerna logo

Monash researchers founding scientists of new GPCR biotechnology company

Two researchers from the Monash Institute of Pharmaceutical Sciences (MIPS) are amongst the co-founders of an exciting new biotechnology company dedicated to discovering and advancing novel small molecule medicines targeting G protein-coupled
1 February, 2022 Research

Monash scientists expose tumour-causing protein

Monash University scientists have discovered the structure of the protein behind neurofibromatosis type 1 (NF1), a common genetic condition that causes tumours to form on nerve tissue.
10 December, 2021 Medicine & health